We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Proposes Mandatory FDA Review of DTC Promotions
AstraZeneca Proposes Mandatory FDA Review of DTC Promotions
November 4, 2005
Saying PhRMA’s voluntary code of conduct doesn’t go far enough, AstraZeneca has proposed that drugmakers submit to mandatory FDA review of all direct-to-consumer (DTC) advertisements prior to use.